Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Celina Dubin, Ester Del Duca & Emma Guttman-Yassky. (2021) The IL-4, IL-13 and IL-31 pathways in atopic dermatitis. Expert Review of Clinical Immunology 17:8, pages 835-852.
Read now
Read now
Deepa S. Mandlik & Satish K. Mandlik. (2020) New perspectives in bronchial asthma: pathological, immunological alterations, biological targets, and pharmacotherapy. Immunopharmacology and Immunotoxicology 42:6, pages 521-544.
Read now
Read now
Angela Moran & Ian D Pavord. (2020) Anti-IL-4/IL-13 for the treatment of asthma: the story so far. Expert Opinion on Biological Therapy 20:3, pages 283-294.
Read now
Read now
Renaud Respaud, Denis Marchand, Christelle Parent, Thibaut Pelat, Philippe Thullier, Jean-François Tournamille, Marie-Claude Viaud-Massuard, Patrice Diot, Mustapha Si-Tahar, Laurent Vecellio & Nathalie Heuzé-Vourc’h. (2014) Effect of formulation on the stability and aerosol performance of a nebulized antibody. mAbs 6:5, pages 1347-1355.
Read now
Read now
Philip M Hansbro, Grace V Scott, Ama-Tawiah Essilfie, Richard Y Kim, Malcolm R Starkey, Duc H Nguyen, Paul D Allen, Gerard E Kaiko, Ming Yang, Jay C Horvat & Paul S Foster. (2013) Th2 cytokine antagonists: potential treatments for severe asthma. Expert Opinion on Investigational Drugs 22:1, pages 49-69.
Read now
Read now
David Gibeon & Andrew N Menzies-Gow. (2012) Targeting interleukins to treat severe asthma. Expert Review of Respiratory Medicine 6:4, pages 423-439.
Read now
Read now
Sabina Antonela Antoniu. (2011) Aclidinium bromide in experimental asthma. Expert Opinion on Investigational Drugs 20:6, pages 871-873.
Read now
Read now
Articles from other publishers (6)
Pierachille Santus, Marina Saad, Giovanni Damiani, Vincenzo Patella & Dejan Radovanovic. (2019) Current and future targeted therapies for severe asthma: Managing treatment with biologics based on phenotypes and biomarkers. Pharmacological Research 146, pages 104296.
Crossref
Crossref
I. P. Shilovskiy, D. V. Eroshkina, A. A. Babakhin & M. R. Khaitov. (2017) Anticytokine therapy of allergic asthma. Molecular Biology 51:1, pages 1-13.
Crossref
Crossref
Girolamo Pelaia, Alessandro Vatrella & Rosario MaselliGirolamo Pelaia, Alessandro Vatrella & Rosario Maselli. 2017. Asthma: Targeted Biological Therapies. Asthma: Targeted Biological Therapies
67
81
.
Karen H. Calhoun. (2015) Asthma treatments: new and emerging therapies. International Forum of Allergy & Rhinology 5:S1, pages S76-S81.
Crossref
Crossref
Rodrigo Vazquez-Lombardi, Brendan Roome & Daniel Christ. (2013) Molecular Engineering of Therapeutic Cytokines. Antibodies 2:4, pages 426-451.
Crossref
Crossref
Tania Maes, Guy F. Joos & Guy G. Brusselle. (2012) Targeting Interleukin-4 in Asthma: Lost in Translation?. American Journal of Respiratory Cell and Molecular Biology 47:3, pages 261-270.
Crossref
Crossref